CNTG (CENTOGENE N.V.) Enterprise Value-to-Revenue Coefficient

Public company logo of CENTOGENE (CNTG)

Centogene N.V. relies on inelastic demand in genetics and a global biobank. This attracts leading bioinformaticians, as evidenced by the EV/Sales history. The current value of characterizes this valuation metric. A proprietary database of rare mutations creates an insurmountable barrier for competitors, providing pharma behemoths with a reliable analytical foundation for their research.

Centogene NV (CNTG): EV/Sales Multiple from 07/04/2022 to 11/20/2026

CNTG (Centogene): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
- business market valuation indicators:
Fundamental company valuation:CNTG, centogene.com
Core merchandise of CENTOGENE, N.V.

For Centogene N.V. (CNTG), the EV/Sales chart reflects the enterprise value of the business relative to sales volumes, which is critical when assessing the scaling of its genetic data AI platform. The trend of this indicator allows for a correlation between the issuer's capital value and revenue from contracts with pharma behemoths, determining the extent of asset overvaluation or undervaluation in the context of rising IT test margins.

Direct competitors

A (Agilent) - Company Value to Revenue Ratio|DGX (Quest Diagnostics) - Company Value to Revenue|Illumina Inc (ILMN) - EV/Sales Multiple|Company Value to Revenue EXAS|Revvity, Inc. (RVTY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple BIO|NNNN (Anbio Biotechnology) - Business Value to Revenue|EV/Sales Multiple SHC (Sotera Health)|Quidel Corporation (QDEL) - Enterprise Value-to-Revenue Multiple|OPK - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio CareDx Corp CDNA|Maravai LifeSciences (MRVI) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Sales Ratio Fulgent Genetics, Inc. FLGT|LAB (Standard BioTools Inc) - EV/Sales Multiple|Cytek Biosciences (CTKB) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple OSUR|Exagen - Company Value to Revenue Ratio|EV/Sales Multiple MDXH (MDxHealth, Inc.)|luciddx.com (LUCD) - Enterprise Value-to-Revenue Multiple|prenetics.com - EV/Sales Multiple|Insight Molecular Diagnostics, Inc. (IMDX) - Company Value to Revenue|TRIB: EV/Sales Multiple|ProPhase - Business Value to Revenue|Enterprise Value-to-Revenue Ratio ainos.com|CODX: Business Value to Revenue|Enterprise Value-to-Revenue Ratio HeartSciences (HSCS)|Company Value to Revenue Biomerica Inc. BMRA|EV/Sales Multiple CDIO (Cardio Diagnostics)|ONCO - Company Value to Revenue|VRAX: Company Value to Revenue|bluejaydx.com (BJDX) - Company Value to Revenue|AWH: EV/Sales Multiple|AXDX: Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio enzo.com|EV/Sales Multiple Fresh2 Group Limited|EV/Sales Multiple GENE|23andMe Holding Co. - Company Value to Revenue Ratio|Psychemedics Inc - Company Value to Revenue